October 27, 2016
Shire spirited up by its antiviral agent (Maribavir) Phase 2 trial results
Shire’s antiviral agent maribavir, studied in the Phase2 trial, has cleared any detectable levels of cytomegalovirus…
Pharmaceuticals, Biotechnology and Life Sciences
Shire’s antiviral agent maribavir, studied in the Phase2 trial, has cleared any detectable levels of cytomegalovirus…